ERIS LIFESCIENCES
|
The Current P/E Ratio of ERIS LIFESCIENCES is 51.05.
Share Price | ₹1,376.2 | Nov 22,2024 |
Market Cap | ₹18,729.4 Cr | |
Earnings-TTM | ₹366.9 Cr | TTM-Consolidated Results |
Price/Earnings | 51.05x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ERIS LIFESCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹18,729.4 Cr] as on Nov 22,2024
(/) Earnings [ ₹366.9 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 51.05x ]
Thus, for ERIS LIFESCIENCES , the investors are currently willing to pay 51.05 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ERIS LIFESCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ERIS LIFESCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of ERIS LIFESCIENCES
PE Ratio Performance Analysis for ERIS LIFESCIENCES
- ERIS LIFESCIENCES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 22.52x.
- ERIS LIFESCIENCES 's operated at median p/e ratio of 23.06x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ERIS LIFESCIENCES 's p/e ratio peaked in Mar2024 at 29.19x.
- ERIS LIFESCIENCES 's p/e ratio hit its five-year low in Mar2020 of 16.88x.
How does ERIS LIFESCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ERIS LIFESCIENCES | 366.86 | 51.05 | 18,729.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 38.73 | 431,352.0 |
CIPLA LTD | 4,485.22 | 26.76 | 120,035.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 18.73 | 101,286.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.21 | 95,461.4 |
DIVIS LABORATORIES LTD | 1,836.00 | 86.75 | 159,265.0 |
MANKIND PHARMA LTD | 2,124.86 | 48.11 | 102,231.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 59.55 | 107,306.0 |
LUPIN LTD | 2,651.94 | 35.61 | 94,430.6 |
AUROBINDO PHARMA LTD | 3,598.83 | 19.75 | 71,069.8 |
ABBOTT INDIA LTD | 1,284.66 | 45.82 | 58,859.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ERIS LIFESCIENCES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.73x |
Max industry PE | 86.75x |
Median industry PE | 38.73x |
Average industry PE | 41.19x |
You may also like the below Video Courses